SCHEMBL7144554

SCHEMBL7144554

Cc1[nH]c2ccc(NC(=O)c3ccc(F)cc3)cc2c1CCN

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 3/20 0.77
MAPT P10636 3/20 0.60
HTR1D P28221 3/20 0.52
HTR6 P50406 3/20 0.52
HTR7 P34969 2/20 0.52
HSD17B10 Q99714 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
MAPK1 P28482 1/20 0.52
CYP2C19 P33261 1/20 0.52
HTR3A P46098 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
RAD52 P43351 1/20 0.50
BLM P54132 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SNCA P37840 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141265 0.88 HTR1F (0.76) HTR1FMAPTHTR1DHTR6HTR7
SCHEMBL7143303 0.87 HTR1F (1.00) HTR1FMAPTHTR1DHTR6HTR7
Hydrochloric Acid SCHEMBL7138726 0.86 HTR1F (0.98) HTR1FMAPTHTR1DHTR6HTR7
SCHEMBL7141051 0.85 HTR1F (0.71) HTR1FMAPTHTR1DHTR6HTR7
SCHEMBL7144771 0.84 HTR1F (0.83) HTR1FMAPTHTR1DHTR6HTR7
SCHEMBL8598857 0.83 HTR1F (0.81) HTR1FMAPTHTR1DHTR6HTR7
SCHEMBL8931377 0.83 HTR1F (0.56) HTR1FMAPTHTR1DHSD17B10NPSR1
Bromide SCHEMBL7138690 0.83 HTR1F (0.80) HTR1FMAPTHTR1DHTR6HTR7
SCHEMBL8931376 0.83 HTR1F (0.55) HTR1FMAPTHTR1DHTR6HTR7
SCHEMBL7146335 0.81 HTR1F (0.66) HTR1FMAPTHTR1DHTR6HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
US-5942536-A USEFUL FOR TREATING MIGRAINE ELI LILLY AND COMPANY (US) 1999-08-24 US disclosed
WO-1997013512-A1 N-[2-SUBSTITUTED-3-(2-AMINOETHYL)-1H-INDOL-5-YL]-AMIDES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1997-04-17 WO disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed